Spratley, Inês Simões Lopo de CarvalhoSantos, FábioKurth, Jonas Maria2022-11-092025-12-172022-09-102021-12-17http://hdl.handle.net/10362/145363The following paper focuses on the development of an investment committee paper for the potential leveraged buy out of Dermapharm Holding SE, a German developer, producer, and distributor of niche prescription and over-the-counter pharmaceuticals. The individual part of the paper focuses on an investment thesis and a respective value creation strategy. Qualitatively, it evaluates the key investment highlights of the company, which translate in to a distinct value creation strategy that nurtures growth by levering sixe valuated growth drivers. Quantitatively, it assesses the impact of each growth driver on the total value creation of thec ase.engPrivate equity challengeCorporate financePrivate equityGenericsLeveraged buyoutInvestment thesisField labDermapharm holding seSpecialty pharmaceuticalsmaster thesis203082796